LORZONE

This brand name is authorized in United States.

Active ingredients

The drug LORZONE contains one active pharmaceutical ingredient (API):

`1`	Chlorzoxazone UNII `H0DE420U8G` - CHLORZOXAZONE
	Chlorzoxazone is a centrally-acting agent for painful musculoskeletal conditions. Data available from animal experiments as well as human study indicate that chlorzoxazone acts primarily at the level of the spinal cord and subcortical areas of the brain where it inhibits multisynaptic reflex arcs involved in producing and maintaining skeletal muscle spasm of varied etiology.
	Read more about Chlorzoxazone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
LORZONE Tablets	MPI, US: SPL/Old	FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	55700-517, 68025-046, 68025-047

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.